Home » Sichuan Kelun-Biotech divulges new HER2-targeting ADCs

To read the full story, subscribe or sign in.

Immuno-oncology

Sichuan Kelun-Biotech divulges new HER2-targeting ADCs

Dec. 10, 2024

Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has synthesized antibody-drug conjugates.

BioWorld Science Cancer Antibody-drug conjugate Immuno-oncology Patents